Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

7.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.8K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
Coagulation01:09

Coagulation

6.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.7K
Introduction to Hemostasis01:05

Introduction to Hemostasis

7.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward improved thrombolysis in ischemic stroke: targeting nonfibrin components.

Research and practice in thrombosis and haemostasis·2026
Same author

Kinetics and dynamics of ionized calcium in a porcine major trauma model.

The journal of trauma and acute care surgery·2026
Same author

Clot composition analysis in ischemic stroke of cancer patients: a systematic review.

BMC neurology·2026
Same author

Novel cryptic ADAMTS13 epitopes uncover a distinct open ADAMTS13 conformation in immune-mediated TTP.

Haematologica·2025
Same author

A novel p.C1130S mutation in a Finnish family with a complex phenotype of von Willebrand disease.

Haematologica·2025
Same author

Association Between Thrombus Composition and Etiology in Patients With Acute Ischemic Stroke Treated by Thrombectomy.

Stroke·2025
Same journal

Contribution of muscarinic acetylcholine receptors to bottom-up amplification of frontal and parietal cortical responses to rare deviant tones in rats.

Neuroscience·2026
Same journal

Developmental switch of GABAergic signaling in starburst amacrine cells driven by chloride transporter dynamics.

Neuroscience·2026
Same journal

Epileptiform discharges are associated with increased theta activity over time in patients with Lewy body dementia.

Neuroscience·2026
Same journal

Response times from gap detection threshold testing relate to cognitive processing speed in young adults.

Neuroscience·2026
Same journal

The timing of visual selective attention in fronto-parietal network: TMS behavioral and brain structural evidence.

Neuroscience·2026
Same journal

Effects of silencing tuberomammillary nucleus histidine decarboxylase-lineage neurons on behavioral responses in a mouse model of motion sickness.

Neuroscience·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.9K

Acute Ischemic Stroke Thrombus Composition.

Sarah Vandelanotte1, Simon F De Meyer1

  • 1Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium.

Neuroscience
|January 7, 2024
PubMed
Summary
This summary is machine-generated.

Ischemic stroke thrombus composition impacts treatment success. Understanding these components can improve recanalization strategies for restoring blood flow and minimizing brain damage.

Keywords:
ischemic strokethrombectomythrombolysisthrombus composition

More Related Videos

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots
06:12

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Published on: July 21, 2023

630
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.7K

Related Experiment Videos

Last Updated: Jul 6, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.9K
Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots
06:12

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Published on: July 21, 2023

630
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.7K

Area of Science:

  • Neurology
  • Vascular Biology
  • Biochemistry

Background:

  • Ischemic stroke results from arterial blockages in the brain, causing irreversible tissue damage.
  • Current treatments aim to restore blood flow via pharmacological thrombolysis (recombinant tissue plasminogen activator, rt-PA) or mechanical thrombectomy.
  • Therapeutic recanalization success is often limited, with thrombus composition being a suspected key factor.

Purpose of the Study:

  • To review the composition of acute ischemic stroke thrombi.
  • To identify recently discovered thrombus components.
  • To analyze how thrombus composition influences stroke treatment outcomes.

Main Methods:

  • Literature review of studies on ischemic stroke thrombus composition.
  • Analysis of identified thrombus components and their role in recanalization.
  • Exploration of potential therapeutic implications.

Main Results:

  • Thrombus composition varies significantly among patients.
  • Specific components, such as fibrin, red blood cells, platelets, and white blood cells, play critical roles.
  • Emerging research identifies novel components influencing treatment response.

Conclusions:

  • Thrombus composition is a critical determinant of recanalization success in ischemic stroke.
  • A deeper understanding of thrombus components can guide the development of more effective stroke therapies.
  • Future strategies may involve tailoring treatments based on individual thrombus characteristics.